Mr. Edwards brings to Biosion nearly 25 years of experience in corporate strategy, Business Development, Alliance Management, M&A, corporate development and communications/investor relations. He has held pharma positions at Lexicon Pharmaceuticals, Valeant Pharmaceuticals, and most recently at Ionis Pharmaceuticals.

During his career in the pharmaceutical industry, Joel managed collaborations that resulted in three NDA approvals while at Ionis and one NDA approval while at Valeant. The most successful partnership and marketed drug he managed has been Spinraza which currently generates over $2B in annual revenue. In total Joel was responsible for bringing in greater than $3.5B in business development and alliance revenue during time at Ionis and managed portfolio of more than 15 alliances. Most recently at Ionis, Joel led the merger and integration of Ionis’ subsidiary, Akcea. In addition, Joel was responsible for building Ionis’ commercialization capabilities and prepare for the company’s first commercial launch.

Joel holds a MBA from Colorado State University and a BS in Psychology from Ball State University, graduating from both institutions with honors distinction.